Browse All

Current Filters

CLEAR FILTER x

TITLE

Novel Technique of Stent Placement via Gateway Balloon in Intracranial Atherosclerosis-associated Large Vessel Occlusion

Author:Ahmad, Rowaid   Memon, Muhammad   Ezzeldin, Mohamad   Biswas, Arundhati   Nisar, Taha   Singla, Amit   Muhammad, Nazar   Shaltoni, Hashem   Kan, Peter   Zaidat, Osama   Khandelwal, Priyank   

Session Name:P3: Cerebrovascular Disease and Interventional Neurology: Stroke Risk Factors and Prevention  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P3.019  

Author Institution:University of Texas Medical Branch Glaveston, Galveston, TX  Rush University Medical Center, Chicago, IL  Carle Foundation Hospital, Urbana, IL  Rutgers New Jersey Medical School, Newark, NJ  Rutgers New Jersey Medical School, Newark, NJ  Cornerstone Family Healthcare, new york, NY  St Vincent Mercy Hospital, Toledo, OH  RUTGERS, The State University of New Jersey, Newark, NJ  

Parkinson's Disease and Loneliness: An Initial Exploration

Author:Warner-Rosen, Tila   Goetz, Christopher   Tosin, Michelle   Gonzalez, David   

Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

Topic:Movement Disorders  

Program Number:P4.005  

Author Institution:Rush University Medical Center, Chicago, IL  

Acceptability and Efficacy of a Novel Parkinson’s Care Partner Training Program

Author:Dizon, Melani   Dawkins, Polly   Fleisher, Jori   

Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

Topic:Movement Disorders  

Program Number:P4.011  

Author Institution:Davis Phinney Foundation, Louisville, CO  Rush University Medical Center, Chicago, IL  

Proteomic Profiling of Angelman Syndrome for Disease-associated Biomarker Discovery

Author:Hawtin, Rachael   Couthouis, Julien   Khan, Showkhin   Wang, Grace   Panagoulias, Jennifer   Gold, Larry   Daugherty, Sean   Kunecki, Dariusz   Berry-Kravis, Elizabeth   Berent, Allyson   

Session Name:P8: Child Neurology and Developmental Neurology: Neurogenetics 2  

Topic:Child Neurology and Developmental Neurology  

Program Number:P8.001  

Author Institution:Ultragenyx Pharmaceutical Inc., Novato, CA  Foundation for Angelman Syndrome Therapeutics, Austin, TX  SomaLogic Operating Co., Inc., Boulder, CO  Rush University Medical Center, Chicago, IL  

Clinical Characteristics of Creatine Transporter Deficiency (CTD): Final Results of the Vigilan Observational Study

Author:Brandabur, Melanie   Bianconi, Simona   Anselm, Irina   Barshop, Bruce A.   Berry-Kravis, Elizabeth   Koeberl, Dwight D   Cecil, Kim M   Hannah-Shmouni, Fady   Longo, Nicola   Mercimek-Andrews, Saadet   Porter, Forbes D   Rahhal, Samar   Sutton, Reid   Blair, Susan   Cimms, Tricia   Zhang, Lin   Farmer PhD, Cristan   Thurm, Audrey   Miller, Judith   

Session Name:P8: Child Neurology and Developmental Neurology: Neurogenetics 2  

Topic:Child Neurology and Developmental Neurology  

Program Number:P8.002  

Author Institution:Ultragenyx Pharmaceutical Inc, Novato, CA  National Institutes of Health, Bethesda, MD  Boston Children's Hospital, Boston, MA  University of California San Diego, La Jolla, CA  Rush University Medical Center, Chicago, IL  Duke University, Durham, NC  Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH  University of Utah, Salt Lake City, UT  , University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada  Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, MD  Baylor College of Medicine, Houston, TX  National Institute of Mental Health, Bethesda, MD  The Children’s Hospital of Philadelphia, Philadelphia, PA